Literature DB >> 29045181

Ductal Carcinoma In Situ: The Whole Truth.

Ujas Parikh1, Chloe M Chhor1, Cecilia L Mercado1.   

Abstract

OBJECTIVE: Ductal carcinoma in situ (DCIS) is a noninvasive malignant breast disease traditionally described as a precursor lesion to invasive breast cancer. With screening mammography, DCIS now accounts for approximately 20% of newly diagnosed cancer cases. DCIS is not well understood because of its heterogeneous nature.
CONCLUSION: Studies have aimed to assess prognostic factors to characterize its risk of invasive potential; however, there still remains a lack of uniformity in workup and treatment. We summarize current knowledge of DCIS and the ongoing controversies.

Entities:  

Keywords:  breast cancer; carcinoma in situ; ductal carcinoma in situ

Mesh:

Year:  2017        PMID: 29045181     DOI: 10.2214/AJR.17.18778

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  11 in total

1.  US and MRI in the evaluation of mammographic BI-RADS 4 and 5 microcalcifications.

Authors:  Ana Hrkac Pustahija; Gordana Ivanac; Boris Brkljacic
Journal:  Diagn Interv Radiol       Date:  2018-07       Impact factor: 2.630

2.  Association between radiologists' and facilities' characteristics and mammography screening detection of ductal carcinoma in situ.

Authors:  Isabelle Théberge; Nathalie Vandal; Linda Perron; Marie-Hélène Guertin
Journal:  Breast Cancer Res Treat       Date:  2021-01-04       Impact factor: 4.872

3.  Ductal carcinoma in situ of the male breast: clinical radiological features and management in a cancer referral center.

Authors:  Luca Nicosia; Germana Lissidini; Manuela Sargenti; Anna Carla Bozzini; Gabriel Farante; José Vila; Chiara Oriecuia; Eleonora Pagan; Vincenzo Bagnardi; Matteo Lazzeroni; Filippo Pesapane; Claudia Sangalli; Viviana Galimberti; Enrico Cassano; Paolo Veronesi
Journal:  Breast Cancer Res Treat       Date:  2022-09-17       Impact factor: 4.624

4.  Chronological Trends of Breast Ductal Carcinoma In Situ: Clinical, Radiologic, and Pathologic Perspectives.

Authors:  Si Eun Lee; Ha Yan Kim; Jung Hyun Yoon; Eun-Kyung Kim; Jee Ye Kim; Min Jung Kim; Ga Ram Kim; Youngjean Vivian Park; Hee Jung Moon
Journal:  Ann Surg Oncol       Date:  2021-07-01       Impact factor: 5.344

5.  Do Eligibility Criteria for Ductal Carcinoma In Situ (DCIS) Active Surveillance Trials Identify Patients at Low Risk for Upgrade to Invasive Carcinoma?

Authors:  Tawakalitu O Oseni; Barbara L Smith; Constance D Lehman; Charmi A Vijapura; Niveditha Pinnamaneni; Manisha Bahl
Journal:  Ann Surg Oncol       Date:  2020-05-16       Impact factor: 5.344

6.  Everolimus Inhibits the Progression of Ductal Carcinoma In Situ to Invasive Breast Cancer Via Downregulation of MMP9 Expression.

Authors:  Guang Chen; Xiao-Fei Ding; Kyle Pressley; Hakim Bouamar; Bingzhi Wang; Guixi Zheng; Larry E Broome; Alia Nazarullah; Andrew J Brenner; Virginia Kaklamani; Ismail Jatoi; Lu-Zhe Sun
Journal:  Clin Cancer Res       Date:  2019-12-23       Impact factor: 12.531

7.  Programmed Cell Death Protein-1 Predicts the Recurrence of Breast Cancer in Patients Subjected to Radiotherapy After Breast-Preserving Surgery.

Authors:  Ruyi Huang; Yiyao Cui; Yujiang Guo
Journal:  Technol Cancer Res Treat       Date:  2018-01-01

8.  A ten-year, single-center experience: Concordance between breast core needle biopsy/vacuum-assisted biopsy and postoperative histopathology in B3 and B5a cases.

Authors:  Mohamed Elsharkawy; Thomas Vestring; Hans-Juergen Raatschen
Journal:  PLoS One       Date:  2020-05-21       Impact factor: 3.240

9.  Potential biomarkers of ductal carcinoma in situ progression.

Authors:  Raquel Spinassé Dettogni; Elaine Stur; Ana Carolina Laus; René Aloísio da Costa Vieira; Márcia Maria Chiquitelli Marques; Iara Viana Vidigal Santana; José Zago Pulido; Laura Fregonassi Ribeiro; Narelle de Jesus Parmanhani; Lidiane Pignaton Agostini; Raquel Silva Dos Reis; Eldamária de Vargas Wolfgramm Dos Santos; Lyvia Neves Rebello Alves; Fernanda Mariano Garcia; Jéssica Aflávio Santos; Diego do Prado Ventorim; Rui Manuel Reis; Iúri Drumond Louro
Journal:  BMC Cancer       Date:  2020-02-12       Impact factor: 4.430

10.  A Model to Predict Upstaging to Invasive Carcinoma in Patients Preoperatively Diagnosed with Low-Grade Ductal Carcinoma In Situ of the Breast.

Authors:  Luca Nicosia; Anna Carla Bozzini; Silvia Penco; Chiara Trentin; Maria Pizzamiglio; Matteo Lazzeroni; Germana Lissidini; Paolo Veronesi; Gabriel Farante; Samuele Frassoni; Vincenzo Bagnardi; Cristiana Fodor; Nicola Fusco; Elham Sajjadi; Enrico Cassano; Filippo Pesapane
Journal:  Cancers (Basel)       Date:  2022-01-12       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.